Discover Community Create You

Loading publication...

Noodle always counts identifier-free feature events for service operation. With your permission, Google Analytics can also estimate audience and engagement. Search text, publication identifiers, cookies, IP addresses and browser fingerprints are never included in Noodle's first-party event counters.

Privacy details

Article

Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assays

14 Oct 2016

Abstract excerpt

// Alan Eastman 1 1 Norris Cotton Cancer Center, Geisel School of Medicine at Dartmouth, Lebanon, NH, USA Correspondence to: Alan Eastman, email: // Keywords : cytotoxicity assays, cell survival, apoptosis, target validation, synergy Received : July 05, 2016 Accepted : October 12, 2016 Published : October 14, 2016 Abstract The high failure rate of anticancer drug discovery and development has consumed billions of...

Read the complete abstract on PubMed

Topics

Share this publication in a Topic to start or enrich a Post.

Share to Cancer Cells and Metastasis
Share to Cancer Genomics and Diagnostics
Share to Computational Drug Discovery Methods

Methodology Data sources Editorial policy Privacy Delete account & data About Contact Helena Bioinformatics

Source

Identifiers

PMID: 27750219
DOI: 10.18632/oncotarget.12673

Provenance

PubMed metadata and Literature Corpus relationships. Corpus snapshot updated 25 Oct 2026.

Related research

Semantic proximity does not establish scientific evidence. Graph snapshot: 2026-09-29.

Research trail→

Click a neighbor to travelStep 1 · 12 closest

Improving anticancer drug development begins with cell culture: misinformation perpetrated by the misuse of cytotoxicity assaysPMID 27750219Read ↗

Challenges in pre-clinical testing of anti-cancer drugs in cell culture and in animal modelsSemantic proximity Read ↗

Changing the Landscape of Solid Tumor Therapy from Apoptosis-Promoting to Apoptosis-Inhibiting StrategiesSemantic proximity Read ↗

A Methodological Workflow to Analyze Synthetic Lethality and Drug Synergism in Cancer Cells.Semantic proximity Read ↗

Challenges and the Advancement in High-Throughput Screening Strategies for Cancer TherapeuticsSemantic proximity Read ↗

Development of Drug-resistant Cell Lines for Experimental ProceduresSemantic proximity Read ↗

In vitro assays and techniques utilized in anticancer drug discoverySemantic proximity Read ↗

Drug GRADE: an integrated analysis of population growth and cell death reveals drug-specific and cancer subtype-specific response profilesSemantic proximity Read ↗

Phase II Studies of Modern Drugs Directed Against New Targets: If You Are Fazed, Too, Then Resist RECISTSemantic proximity Read ↗

Systems for Identifying New Drugs Are Often FaultySemantic proximity Read ↗

Cell line-based platforms to evaluate the therapeutic efficacy of candidate anticancer agents.Semantic proximity Read ↗

Phenotypic screening in cancer drug discovery - past, present and future.Semantic proximity Read ↗

Pharmacological manipulation of the cell cycle and metabolism to protect normal tissues against conventional anticancer drugsSemantic proximity Read ↗

⌁Select a neighboring publication to make it the new centre.